<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Laboratory medicine</title>
            <link>https://medicalxpress.com/biomedical-technology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Laboratory medicine</description>

                            <item>
                    <title>AI helps pathologists find signs of preeclampsia, advancing diagnosis and treatment</title>
                    <description>Preeclampsia is one of the leading causes of pregnancy-related death. Even after a healthy delivery, mother and baby can go home only to show signs of a postpartum hypertensive disorder days or weeks later.</description>
                    <link>https://medicalxpress.com/news/2026-09-ai-pathologists-preeclampsia-advancing-diagnosis.html</link>
                    <category></category>
                    <pubDate>Tue, 15 Sep 2026 11:40:04 EDT</pubDate>
                    <guid isPermaLink="false">news708688741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/pregnant-8.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Microproteins provide new playbook for Alzheimer&#039;s research</title>
                    <description>Scientists researching Alzheimer&#039;s disease and neurodegeneration have been playing a difficult game. Their scientific playbook has been limited by the available resources that, while capturing loads of genes, proteins and cells, have been missing something: microproteins.</description>
                    <link>https://medicalxpress.com/news/2026-09-microproteins-playbook-alzheimer.html</link>
                    <category></category>
                    <pubDate>Mon, 14 Sep 2026 18:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news708624782</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/microproteins-provide.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Fine-tuning medical AI can improve diagnosis but also creates privacy risks</title>
                    <description>Qingyu Chen, PhD, and his team set out to study how artificial intelligence language models are adapted for medicine and found that what these models memorize can be both useful and risky. A model may retain valuable medical knowledge, but in a controlled study using real hospital records, the same fine-tuning—the added training that adapts a model to a specific task—that improved diagnostic performance also made it more likely to reproduce material it had seen during training, including sensitive patient information.</description>
                    <link>https://medicalxpress.com/news/2026-09-fine-tuning-medical-ai-diagnosis.html</link>
                    <category></category>
                    <pubDate>Mon, 14 Sep 2026 08:40:10 EDT</pubDate>
                    <guid isPermaLink="false">news708593462</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/making-medical-ai-smar.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Early blood protein clues could identify children at risk of cardiometabolic disease</title>
                    <description>Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight-loss drugs widely used by adults.</description>
                    <link>https://medicalxpress.com/news/2026-09-early-blood-protein-clues-children.html</link>
                    <category></category>
                    <pubDate>Sun, 13 Sep 2026 09:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news708353097</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/2-bloodtest.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI-enabled analysis of pathology slides may help assess risk of pancreatic cancer recurrence</title>
                    <description>Mayo Clinic researchers have found that artificial intelligence (AI)-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery.</description>
                    <link>https://medicalxpress.com/news/2026-09-ai-enabled-analysis-pathology-pancreatic.html</link>
                    <category></category>
                    <pubDate>Fri, 11 Sep 2026 13:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news708344041</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/microscope.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A resource to help hospitals build the business case for diagnostic stewardship</title>
                    <description>The Society for Healthcare Epidemiology of America (SHEA) has published a new resource describing how diagnostic stewardship can improve patient outcomes, strengthen hospital quality metrics and reduce health care costs.</description>
                    <link>https://medicalxpress.com/news/2026-09-resource-hospitals-business-case-diagnostic.html</link>
                    <category></category>
                    <pubDate>Fri, 11 Sep 2026 09:40:09 EDT</pubDate>
                    <guid isPermaLink="false">news708328022</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/2-hospital.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Sewers reveal signs of chlamydia near college campus with few reported cases</title>
                    <description>A city&#039;s sewers say a lot about its residents. Sick people often shed pathogens in their waste, adding traceable amounts of bacteria and viruses to wastewater. Testing that wastewater offers a simple, low-cost way to monitor the spread of disease—a practice that began with polio in the 1940s and became more widespread during the COVID-19 pandemic. Today, the CDC&#039;s wastewater monitoring program tests for a variety of common and emerging viruses.</description>
                    <link>https://medicalxpress.com/news/2026-09-sewers-reveal-chlamydia-college-campus.html</link>
                    <category></category>
                    <pubDate>Thu, 10 Sep 2026 13:20:07 EDT</pubDate>
                    <guid isPermaLink="false">news708264602</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2021/wastewater.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Protein shape shift reveals how the mpox virus begins replicating</title>
                    <description>The way two mpox virus proteins change shape as they bind together acts like a switch that starts the process of viral replication, a study led by researchers at the Blavatnik Institute at Harvard Medical School reveals. This kind of detailed structural information promises to help scientists, armed with a new generation of AI-powered virtual screening tools, target their search for ways to inhibit viral replication, treat mpox and related diseases, and prepare for emerging pathogens.</description>
                    <link>https://medicalxpress.com/news/2026-09-protein-shift-reveals-mpox-virus.html</link>
                    <category></category>
                    <pubDate>Thu, 10 Sep 2026 12:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news708258095</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-reveal-how-8.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood protein analysis could help diagnose rare diseases missed by genome sequencing</title>
                    <description>Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have shown that measuring proteins in the blood can provide important additional clues about the effects of genetic variants, helping to identify diagnoses and potential new disease-causing genes that genome sequencing alone has been unable to resolve.</description>
                    <link>https://medicalxpress.com/news/2026-09-blood-protein-analysis-rare-diseases.html</link>
                    <category></category>
                    <pubDate>Wed, 09 Sep 2026 14:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news708178647</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/blood-protein-test.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Algorithmic tool may improve screening of patients for an Alzheimer&#039;s clinical trial</title>
                    <description>A new blood-based screening algorithm dramatically reduced the number of unnecessary PET scans needed to recruit patients at risk of Alzheimer&#039;s disease for a clinical trial, according to research from scientists at the Keck School of Medicine of USC published in the journal Alzheimer&#039;s &amp; Dementia.</description>
                    <link>https://medicalxpress.com/news/2026-09-algorithmic-tool-screening-patients-alzheimer.html</link>
                    <category></category>
                    <pubDate>Wed, 09 Sep 2026 07:00:07 EDT</pubDate>
                    <guid isPermaLink="false">news708002941</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/blood-test-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Mpox outbreak in 2022 caused by less severe form of the virus, study reveals</title>
                    <description>The strain of mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped it spread faster, a new study from the University of Surrey reports. The findings, published in the journal Nature Communications, show that the virus acquired mutations before it spread globally. These mutations, which are absent from forms of the virus currently circulating in parts of Africa, cause less severe symptoms in patients, who may have unknowingly spread the virus across borders.</description>
                    <link>https://medicalxpress.com/news/2026-09-mpox-outbreak-severe-virus-reveals.html</link>
                    <category></category>
                    <pubDate>Tue, 08 Sep 2026 17:20:07 EDT</pubDate>
                    <guid isPermaLink="false">news708105182</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/monkeypox.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Strengthening responses to Bundibugyo virus outbreaks with faster diagnostics and deeper insights</title>
                    <description>The current outbreak of Bundibugyo virus (BDBV) in the Democratic Republic of the Congo highlights the challenges of responding to rare but potentially devastating infectious diseases. Two studies led by researchers from the German Center for Infection Research (DZIF), together with other national and international collaborators, now provide important insights for outbreak response. One study demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer some cross-protection. Both studies were published this month in The Lancet Infectious Diseases.</description>
                    <link>https://medicalxpress.com/news/2026-09-responses-bundibugyo-virus-outbreaks-faster.html</link>
                    <category></category>
                    <pubDate>Tue, 08 Sep 2026 15:20:09 EDT</pubDate>
                    <guid isPermaLink="false">news708093961</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-strengthen.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists in China discover new tick-borne virus that causes flu-like illness</title>
                    <description>Scientists in China have identified a novel tick-borne virus that causes an influenza-like illness characterized by fever, fatigue, gastrointestinal (GI) symptoms and abnormal lab findings. The team, led by researchers from the State Key Laboratory of Pathogen and Biosecurity in Beijing, has designated the new orthonairovirus as the Asian longhorned tick nairovirus (ALTNV).</description>
                    <link>https://medicalxpress.com/news/2026-09-scientists-china-borne-virus-flu.html</link>
                    <category></category>
                    <pubDate>Mon, 07 Sep 2026 10:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news707992776</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-in-china-di.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New blood biomarkers reveal how common muscular dystrophy treatment may impair overall growth</title>
                    <description>In a study published in Scientific Reports, an international, multidisciplinary research team that included Binghamton University researchers identified a set of blood proteins that may explain why the corticosteroid prednisone, although beneficial in treating Duchenne muscular dystrophy (DMD), can interfere with childhood growth and bone health.</description>
                    <link>https://medicalxpress.com/news/2026-09-blood-biomarkers-reveal-common-muscular.html</link>
                    <category></category>
                    <pubDate>Fri, 04 Sep 2026 13:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news707745541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-blood-biomarkers-r.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA clears blood test for Alzheimer disease</title>
                    <description>The U.S. Food and Drug Administration has cleared the PrecivityAD2 test for adults 40 and older presenting with signs or symptoms of cognitive impairment and undergoing evaluation for Alzheimer&#039;s disease or other forms of cognitive decline.</description>
                    <link>https://medicalxpress.com/news/2026-09-fda-blood-alzheimer-disease.html</link>
                    <category></category>
                    <pubDate>Thu, 03 Sep 2026 15:20:11 EDT</pubDate>
                    <guid isPermaLink="false">news707657613</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-clears-blood-test-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Urine test identifies more than nine in ten bladder cancers, clinical study finds</title>
                    <description>New research has found that more than 9 in 10 patients with bladder cancer were identified through a noninvasive urine test after urgent referral. The study, led by the University of Birmingham and Nonacus Ltd., involved 964 patients across seven NHS urology departments to examine the real-world significance of testing for bladder cancer using a commercially available urine test. GALEAS™ Bladder, which tests genomic information from a patient&#039;s urine for traces of bladder cancer, detected 71 of 77 cancers (92.2%) among the nearly 1,000 patients.</description>
                    <link>https://medicalxpress.com/news/2026-09-urine-ten-bladder-cancers-clinical.html</link>
                    <category></category>
                    <pubDate>Wed, 02 Sep 2026 10:00:09 EDT</pubDate>
                    <guid isPermaLink="false">news707557312</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/urinetest.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>One flash of red light could check health of bioprinted tissue and implants</title>
                    <description>Using 3D printers to create complex structures from biocompatible materials that can include living cells has the potential to revolutionize medicine. This process—3D bioprinting—has powered breakthroughs in tissue engineering, medical implants and reconstructive surgery and may ultimately allow for the creation of transplantable human organs.</description>
                    <link>https://medicalxpress.com/news/2026-09-red-health-bioprinted-tissue-implants.html</link>
                    <category></category>
                    <pubDate>Tue, 01 Sep 2026 14:20:06 EDT</pubDate>
                    <guid isPermaLink="false">news707483470</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/instantly-measure-tiss-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tumor &#039;floor plans&#039; may predict immunotherapy response better than current biomarkers</title>
                    <description>Spatial transcriptomics is a powerful tool for creating a detailed map of not just how genes are expressed in a piece of tissue, but also where genetic activity takes place in different cells and locations within the tissue. This is especially valuable for studying tumors, which each have their own unique microenvironment that affects how they behave.</description>
                    <link>https://medicalxpress.com/news/2026-08-tumor-floor-immunotherapy-response-current.html</link>
                    <category></category>
                    <pubDate>Mon, 31 Aug 2026 15:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news707407382</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-tools-predict-whic.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Machine learning model identifies heart failure with reduced ejection fraction using routine lab indicators</title>
                    <description>A 13-indicator routine laboratory model shows moderate discrimination for distinguishing heart failure with reduced ejection fraction (HFrEF), according to a study published online Aug. 9 in Frontiers in Cardiovascular Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-08-machine-heart-failure-ejection-fraction.html</link>
                    <category></category>
                    <pubDate>Sun, 30 Aug 2026 07:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news707137615</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/machine-learning-model-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI and proteomics uncover seven blood proteins linked to vasculitis remission</title>
                    <description>Vasculitis is a disease in which the immune system mistakenly attacks blood vessel walls, causing them to become inflamed. If left untreated, the rare disease can severely damage organs, including the kidneys and lungs. Physicians can treat vasculitis with immunosuppressive medications. But because these drugs often cause serious side effects, they have long sought a way to identify patients in remission to avoid treating them unnecessarily or minimize treatment regimens.</description>
                    <link>https://medicalxpress.com/news/2026-08-ai-proteomics-uncover-blood-proteins.html</link>
                    <category></category>
                    <pubDate>Wed, 26 Aug 2026 15:20:08 EDT</pubDate>
                    <guid isPermaLink="false">news706974122</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/proteomics-and-ai-iden.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New approach cuts sepsis diagnosis from days to hours</title>
                    <description>Sepsis, a life-threatening condition that stems from the body trying to fight off an infection, plagues more than 1.5 million patients a year in the U.S. alone, with one in three deaths recorded in hospitals attributed in part to sepsis. Despite the severity of the condition, which can kill in as little as 12 hours, it takes between two and seven days for most traditional approaches to definitively identify sepsis-causing bacteria in blood infections.</description>
                    <link>https://medicalxpress.com/news/2026-08-approach-sepsis-diagnosis-days-hours.html</link>
                    <category></category>
                    <pubDate>Wed, 26 Aug 2026 14:00:24 EDT</pubDate>
                    <guid isPermaLink="false">news706952341</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-approach-cuts-seps.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Wastewater may offer an early warning of pertussis outbreaks</title>
                    <description>Pertussis, or whooping cough, continues to cause periodic outbreaks worldwide and can be especially dangerous for infants who have not completed vaccination. Yet conventional surveillance depends on people seeking medical care, being tested, diagnosed and reported, which can delay recognition of changes in community transmission.</description>
                    <link>https://medicalxpress.com/news/2026-08-wastewater-early-pertussis-outbreaks.html</link>
                    <category></category>
                    <pubDate>Wed, 26 Aug 2026 12:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news706956995</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/wastewater-may-offer-a.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>AI matches human pathologists in predicting breast cancer outcomes from immune cells</title>
                    <description>Two major international Peter Mac-led studies have found AI models were just as good as human pathologists at a task that predicts outcomes for patients with breast cancer.</description>
                    <link>https://medicalxpress.com/news/2026-08-ai-human-pathologists-breast-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 26 Aug 2026 09:40:08 EDT</pubDate>
                    <guid isPermaLink="false">news706954271</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/breast-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Additional transfusion risk emerges for patients with tick-borne alpha-gal syndrome, beyond meat allergy</title>
                    <description>A new multi-institutional study led by researchers at Dartmouth Health and Geisel School of Medicine at Dartmouth suggests that alpha-gal syndrome, a tick-borne disease that can result in a chronic allergy to meat and animal byproducts, also may complicate certain patients&#039; ability to safely receive a blood plasma or platelet transfusion.</description>
                    <link>https://medicalxpress.com/news/2026-08-additional-transfusion-emerges-patients-borne.html</link>
                    <category></category>
                    <pubDate>Tue, 25 Aug 2026 13:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news706878721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tick-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A painless punch with a microneedle patch could detect kidney disease earlier</title>
                    <description>Kidney disease is silent in its early stages, progressing without symptoms until the disease is advanced. Researchers in the McKelvey School of Engineering at Washington University in St. Louis, in collaboration with researchers at WashU Medicine and Texas A&amp;M University, have been developing a minimally invasive method to improve diagnosis at earlier stages.</description>
                    <link>https://medicalxpress.com/news/2026-08-painless-microneedle-patch-kidney-disease.html</link>
                    <category></category>
                    <pubDate>Tue, 25 Aug 2026 11:20:13 EDT</pubDate>
                    <guid isPermaLink="false">news706869721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-painless-punch-with.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood test shows promise for detecting breast cancer recurrence</title>
                    <description>A research team at Kumamoto University has developed a blood-based approach that could help detect breast cancer recurrence by looking beyond conventional genetic mutations and examining how DNA is packaged inside cells. The study, published in Cancer Research Communications, analyzed cell-free DNA (cfDNA)—tiny DNA fragments circulating in the bloodstream—from 150 breast cancer samples, including 105 from primary breast cancer and 45 from recurrent or metastatic disease.</description>
                    <link>https://medicalxpress.com/news/2026-08-blood-breast-cancer-recurrence.html</link>
                    <category></category>
                    <pubDate>Mon, 24 Aug 2026 11:00:09 EDT</pubDate>
                    <guid isPermaLink="false">news706784294</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/blood-test-shows-promi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA clears blood test to aid evaluation for Alzheimer&#039;s disease</title>
                    <description>The U.S. Food and Drug Administration (FDA) has cleared an innovative blood test for marketing. The test&#039;s underlying technology was invented at Washington University School of Medicine in St. Louis for the early diagnosis of Alzheimer&#039;s disease. The test, known as PrecivityAD2, was developed and validated by C2N Diagnostics, a WashU startup.</description>
                    <link>https://medicalxpress.com/news/2026-08-fda-blood-aid-alzheimer-disease.html</link>
                    <category></category>
                    <pubDate>Mon, 24 Aug 2026 07:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news706765741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-clears-blood-test.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers find cold storage platelets safe and effective</title>
                    <description>A new study has found platelets kept in cold storage are as effective at treating bleeding and have a longer shelf life than platelets stored at room temperature. Dr. James Preuss and Dr. Warren Pavey, from The University of Western Australia&#039;s Medical School, were co-authors of the study published in JAMA that could make platelets used in cardiac surgery more readily available in Australia.</description>
                    <link>https://medicalxpress.com/news/2026-08-cold-storage-platelets-safe-effective.html</link>
                    <category></category>
                    <pubDate>Sat, 22 Aug 2026 08:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news706275568</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/platelet-donation.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>FDA authorizes first standalone robotic device to draw blood</title>
                    <description>The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient&#039;s arm. Marketing authorization was granted to Vitestro.</description>
                    <link>https://medicalxpress.com/news/2026-08-fda-authorizes-standalone-robotic-device.html</link>
                    <category></category>
                    <pubDate>Fri, 21 Aug 2026 23:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news706528985</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/fda-authorizes-first-s.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Gene markers quantify damage in individual kidney and liver cells</title>
                    <description>Researchers at the University of Cologne, University Hospital Cologne and the Max Planck Institute for Metabolism Research have developed a method that, for the first time, enables damage to individual cells to be precisely quantified. The method uses molecular markers—specifically gene expression—and enables detailed analysis of disease progression in individual tissue samples, such as a biopsy.</description>
                    <link>https://medicalxpress.com/news/2026-08-gene-markers-quantify-individual-kidney.html</link>
                    <category></category>
                    <pubDate>Fri, 21 Aug 2026 14:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news706537561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/gene-markers-quantify.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
